Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Equity Ratio (2016 - 2025)

PAVmed has reported Equity Ratio over the past 6 years, most recently at 0.57 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 806.06% year-over-year to 0.57; the TTM value through Dec 2025 reached 0.57, up 806.06%, while the annual FY2025 figure was 0.57, 806.06% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.57 at PAVmed, down from 0.85 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.94 in Q1 2021 and troughed at 0.73 in Q4 2023.
  • A 5-year average of 0.33 and a median of 0.45 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: surged 3918.04% in 2021 and later tumbled 2959.23% in 2024.
  • Year by year, Equity Ratio stood at 0.91 in 2021, then crashed by 77.82% to 0.2 in 2022, then crashed by 458.03% to 0.73 in 2023, then soared by 88.78% to 0.08 in 2024, then surged by 806.06% to 0.57 in 2025.
  • Business Quant data shows Equity Ratio for PAVM at 0.57 in Q4 2025, 0.85 in Q3 2025, and 0.64 in Q2 2025.